The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Clinical Diagnosis and Management of Breast Cancer
Open accessAbstract
The diagnosis and management of breast cancer are undergoing a paradigm shift from a one-size-fits-all approach to an era of personalized medicine. Sophisticated diagnostics, including molecular imaging and genomic expression profiles, enable improved tumor characterization. These diagnostics, combined with newer surgical techniques and radiation therapies, result in a collaborative multidisciplinary approach to minimizing recurrence and reducing treatment-associated morbidity. This article reviews the diagnosis and treatment of breast cancer, including screening, staging, and multidisciplinary management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
Paik, S., Shak, S., Tang, G., Kim, C., Baker, J., Cronin, M., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,277
Giuliano, A. E. (2011) · JAMA · doi:10.1001/jama.2011.90 · Cited by 2,942
Adjuvant Trastuzumab in HER2-Positive Breast Cancer
Slamon, D., Eiermann, W., Robert, N., Pienkowski, T., Martin, M., Press, M., Mackey, J., Glaspy, J., Chan, A., Pawlicki, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa0910383 · Cited by 2,775
Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer
Berry, D. A., Cronin, K. A., Plevritis, S. K., Fryback, D. G., Clarke, L., Zelen, M., Mandelblatt, J. S., Yakovlev, A. Y., Habbema, J. D. F., & Feuer, E. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050518 · Cited by 2,460
Gianni, L., Pienkowski, T., Im, Y.-H., Roman, L., Tseng, L.-M., Liu, M.-C., Lluch, A., Staroslawska, E., de la Haba-Rodriguez, J., Im, S.-A., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70336-9 · Cited by 2,374
EBCTCG (Early Breast Cancer Trialists' Collaborative Group) (2014) · The Lancet · doi:10.1016/s0140-6736(14)60488-8 · Cited by 2,254
Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer
Swain, S. M., Baselga, J., Kim, S.-B., Ro, J., Semiglazov, V., Campone, M., Ciruelos, E., Ferrero, J.-M., Schneeweiss, A., Heeson, S., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1413513 · Cited by 2,164
Prognostic and predictive factors in breast cancer by immunohistochemical analysis.
Allred, D. C., Harvey, J. M., Berardo, M. D., & Gm, C. (1998) · PubMed · Cited by 2,143
Davies, C., Pan, H., Godwin, J., Gray, R., Arriagada, R., Raina, V., Abraham, M., Alencar, V. H. M., Badran, A., Bonfill, X., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61963-1 · Cited by 2,044
Finn, R. S., Crown, J. P., Lang, I., Boer, K., Bondarenko, I. M., Kulyk, S. O., Ettl, J., Patel, R., Pinter, T., Schmidt, M., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71159-3 · Cited by 1,900 · cited 1×
“Recent data also support the addition of palbociclib, an oral inhibitor of cyclin-dependent kinases 4 and 6, to first-line letrozole (49) and second-line fulvestrant (50) in patients with ER-positive metastatic disease.”
BackgroundLong-Term Results of Hypofractionated Radiation Therapy for Breast Cancer
Whelan, T. J., Pignol, J.-P., Levine, M. N., Julian, J. A., MacKenzie, R., Parpia, S., Shelley, W., Grimard, L., Bowen, J., Lukka, H., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0906260 · Cited by 1,878
Veronesi, U., Saccozzi, R., Del Vecchio, M., Banfi, A., Clemente, C., De Lena, M., Gallus, G., Greco, M., Luini, A., Marubini, E., et al. (1981) · New England Journal of Medicine · doi:10.1056/nejm198107023050102 · Cited by 1,599
Palbociclib in hormone-receptor-positive advanced breast cancer
Turner, N. C., Ro, J., André, F., Loi, S., Verma, S., Iwata, H., Harbeck, N., Loibl, S., Huang Bartlett, C., Zhang, K., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1505270 · Cited by 1,590
Boughey, J. C. (2013) · JAMA · doi:10.1001/jama.2013.278932 · Cited by 1,588
Berg, W. A. (2008) · JAMA · doi:10.1001/jama.299.18.2151 · Cited by 1,526
Kuehn, T., Bauerfeind, I., Fehm, T., Fleige, B., Hausschild, M., Helms, G., Lebeau, A., Liedtke, C., Minckwitz, G. V., Nekljudova, V., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70166-9 · Cited by 1,485
Haviland, J. S., Owen, J. R., Dewar, J. A., Agrawal, R. K., Barrett, J., Barrett-Lee, P. J., Dobbs, H. J., Hopwood, P., Lawton, P. A., Magee, B. J., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70386-3 · Cited by 1,470
Berg, W. A., Gutierrez, L., NessAiver, M. S., Carter, W. B., Bhargavan, M., Lewis, R. S., & Ioffe, O. B. (2004) · Radiology · doi:10.1148/radiol.2333031484 · Cited by 1,439
Albain, K. S., Barlow, W. E., Shak, S., Hortobagyi, G. N., Livingston, R. B., Yeh, I.-T., Ravdin, P., Bugarini, R., Baehner, F. L., Davidson, N. E., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70314-6 · Cited by 1,407
Hughes, K. S., Schnaper, L. A., Bellon, J. R., Cirrincione, C. T., Berry, D. A., McCormick, B., Muss, H. B., Smith, B. L., Hudis, C. A., Winer, E. P., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.2615 · Cited by 1,310
Regional Nodal Irradiation in Early-Stage Breast Cancer
Whelan, T. J., Olivotto, I. A., Parulekar, W. R., Ackerman, I., Chua, B. H., Nabid, A., Vallis, K. A., White, J. R., Rousseau, P., Fortin, A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1415340 · Cited by 1,294
Schneeweiss, A., Chia, S., Hickish, T., Harvey, V., Eniu, A., Hegg, R., Tausch, C., Seo, J. H., Tsai, Y.-F., Ratnayake, J., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt182 · Cited by 1,264
Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer
Poortmans, P. M., Collette, S., Kirkove, C., Van Limbergen, E., Budach, V., Struikmans, H., Collette, L., Fourquet, A., Maingon, P., Valli, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1415369 · Cited by 1,005
Perez, E. A., Romond, E. H., Suman, V. J., Jeong, J.-H., Sledge, G., Geyer, C. E., Martino, S., Rastogi, P., Gralow, J., Swain, S. M., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.5730 · Cited by 978
MRI Evaluation of the Contralateral Breast in Women with Recently Diagnosed Breast Cancer
Lehman, C. D., Gatsonis, C., Kuhl, C. K., Hendrick, R. E., Pisano, E. D., Hanna, L., Peacock, S., Smazal, S. F., Maki, D. D., Julian, T. B., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065447 · Cited by 945
Lucci, A., McCall, L. M., Beitsch, P. D., Whitworth, P. W., Reintgen, D. S., Blumencranz, P. W., Leitch, A. M., Saha, S., Hunt, K. K., & Giuliano, A. E. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.4062 · Cited by 920
Breast Cancer Screening Using Tomosynthesis in Combination With Digital Mammography
Friedewald, S. M., Rafferty, E. A., Rose, S. L., Durand, M. A., Plecha, D. M., Greenberg, J. S., Hayes, M. K., Copit, D. S., Carlson, K. L., Cink, T. M., et al. (2014) · JAMA · doi:10.1001/jama.2014.6095 · Cited by 851
Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer
Tolaney, S. M., Barry, W. T., Dang, C. T., Yardley, D. A., Moy, B., Marcom, P. K., Albain, K. S., Rugo, H. S., Ellis, M., Shapira, I., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1406281 · Cited by 753
Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
Pagani, O., Regan, M. M., Walley, B. A., Fleming, G. F., Colleoni, M., Láng, I., Gomez, H. L., Tondini, C., Burstein, H. J., Perez, E. A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1404037 · Cited by 749
Krop, I. E., Kim, S.-B., González-Martín, A., LoRusso, P. M., Ferrero, J.-M., Smitt, M., Yu, R., Leung, A. C. F., & Wildiers, H. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70178-0 · Cited by 724
Overview of the Randomized Trials of Radiotherapy in Ductal Carcinoma In Situ of the Breast
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2010) · JNCI Monographs · doi:10.1093/jncimonographs/lgq039 · Cited by 672
A Systematic Assessment of Benefits and Risks to Guide Breast Cancer Screening Decisions
Pace, L. E., & Keating, N. L. (2014) · JAMA · doi:10.1001/jama.2014.1398 · Cited by 461
Anderson, S. J., Wapnir, I., Dignam, J. J., Fisher, B., Mamounas, E. P., Jeong, J.-H., Geyer, C. E., Wickerham, D. L., Costantino, J. P., & Wolmark, N. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.8424 · Cited by 458
Breast Reconstruction after Surgery for Breast Cancer
Cordeiro, P. G. (2008) · New England Journal of Medicine · doi:10.1056/nejmct0802899 · Cited by 395
McCormick, B., Winter, K., Hudis, C., Kuerer, H. M., Rakovitch, E., Smith, B. L., Sneige, N., Moughan, J., Shah, A., Germain, I., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.9029 · Cited by 392
Hughes, L. L., Wang, M., Page, D. L., Gray, R., Solin, L. J., Davidson, N. E., Lowen, M. A., Ingle, J. N., Recht, A., & Wood, W. C. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.21.8560 · Cited by 372
ACR Appropriateness Criteria Breast Cancer Screening
Mainiero, M. B., Lourenco, A., Mahoney, M. C., Newell, M. S., Bailey, L., Barke, L. D., D'Orsi, C., Harvey, J. A., Hayes, M. K., Huynh, P. T., et al. (2013) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2012.09.036 · Cited by 342
Screening Breast Ultrasound: Past, Present, and Future
Brem, R. F., Lenihan, M. J., Lieberman, J., & Torrente, J. (2015) · American Journal of Roentgenology · doi:10.2214/ajr.13.12072 · Cited by 307
Preoperative Magnetic Resonance Imaging in Breast Cancer: Meta-Analysis of Surgical Outcomes
Houssami, N., Turner, R., & Morrow, M. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e31827a8d17 · Cited by 293
De La Cruz, L., Moody, A. M., Tappy, E. E., Blankenship, S. A., & Hecht, E. M. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4739-1 · Cited by 284
Svahn, T. M., Houssami, N., Sechopoulos, I., & Mattsson, S. (2015) · The Breast · doi:10.1016/j.breast.2014.12.002 · Cited by 233
Jatoi, I., & Proschan, M. A. (2005) · American Journal of Clinical Oncology · doi:10.1097/01.coc.0000156922.58631.d7 · Cited by 227
Bekelman, J. E., Sylwestrzak, G., Barron, J., Liu, J., Epstein, A. J., Freedman, G., Malin, J., & Emanuel, E. J. (2014) · JAMA · doi:10.1001/jama.2014.16616 · Cited by 215
Self-citationAccelerated Partial Breast Irradiation As a Part of Breast Conservation Therapy
Arthur, D. W., & Vicini, F. A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.045 · Cited by 197
Houssami, N., Turner, R., Macaskill, P., Turnbull, L. W., McCready, D. R., Tuttle, T. M., Vapiwala, N., & Solin, L. J. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.52.7515 · Cited by 192
Gradishar, W. J., Anderson, B. O., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., Goldstein, L. J., et al. (2014) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2014.0058 · Cited by 185
Tailored Supplemental Screening for Breast Cancer: What Now and What Next?
Berg, W. A. (2009) · American Journal of Roentgenology · doi:10.2214/ajr.08.1706 · Cited by 181
Prone vs Supine Positioning for Breast Cancer Radiotherapy
Formenti, S. C., DeWyngaert, J. K., Jozsef, G., & Goldberg, J. D. (2012) · JAMA · doi:10.1001/2012.jama.10759 · Cited by 164
Mavroudis, D., Saloustros, E., Malamos, N., Kakolyris, S., Boukovinas, I., Papakotoulas, P., Kentepozidis, N., Ziras, N., & Georgoulias, V. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv213 · Cited by 162
Onega, T., Beaber, E. F., Sprague, B. L., Barlow, W. E., Haas, J. S., Tosteson, A. N. A., Schnall, M. D., Armstrong, K., Schapira, M. M., Geller, B. M., et al. (2014) · Cancer · doi:10.1002/cncr.28771 · Cited by 148
Freedman, G. M., Li, T., Nicolaou, N., Chen, Y., Ma, C. C.-M., & Anderson, P. R. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.08.071 · Cited by 114
Self-citationBreast cancer biomarkers and molecular medicine
Ross, J. S., Linette, G. P., Stec, J. J., Clark, E. A., Ayers, M., Leschly, N., Symmans, W. F., Hortobágyi, G. N., & Pusztai, L. (2003) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.3.5.573 · Cited by 113
Fuller, M. S., Lee, C. I., & Elmore, J. G. (2015) · Medical Clinics of North America · doi:10.1016/j.mcna.2015.01.002 · Cited by 107
FDG-PET/CT in the staging of local/regional metastases in breast cancer
Robertson, I., Hand, F., & Kell, M. (2011) · The Breast · doi:10.1016/j.breast.2011.07.002 · Cited by 75
Eldredge-Hindy, H., Lockamy, V. L., Crawford, A. G., Nettleton, V., Werner‐Wasik, M., Siglin, J., Simone, N. L., Sidhu, K., & Anne, P. R. (2015) · Practical Radiation Oncology · doi:10.1016/j.prro.2014.06.004 · Cited by 61
Next-Generation Sequencing in Clinical Oncology: Next Steps Towards Clinical Validation
Bennett, N. J., & Farah, C. S. (2014) · Cancers · doi:10.3390/cancers6042296 · Cited by 56
Keller, L. M. M., Sopka, D. M., Li, T., Klayton, T. L., Li, J. S., Anderson, P. R., Bleicher, R. J., Sigurdson, E. R., & Freedman, G. M. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.01.069 · Cited by 56
Self-citationXu, G., Zhao, L., & He, Z. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.105049 · Cited by 55
Accelerated partial breast irradiation
Beitsch, P. D., Shaitelman, S. F., & Vicini, F. A. (2011) · Journal of Surgical Oncology · doi:10.1002/jso.21785 · Cited by 48
Neoadjuvant endocrine therapy for resectable breast cancer: A systematic review and meta-analysis
Leal, F. R. P., Liutti, V. T., Santos, V. C. A., de Figueiredo, M. A. N., Macedo, L. T., Rinck, J. A., & Sasse, A. D. (2015) · The Breast · doi:10.1016/j.breast.2015.03.004 · Cited by 33
Cited by
Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers
Larionova, I., Tuguzbaeva, G., Ponomaryova, A., Stakheyeva, M., Cherdyntseva, N., Pavlov, V., Choinzonov, E., & Kzhyshkowska, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.566511 · Cited by 392
Therapeutic Targeting of CDK12/CDK13 in Triple-Negative Breast Cancer
Quereda, V., Bayle, S., Vena, F., Frydman, S. M., Monastyrskyi, A., Roush, W. R., & Duckett, D. R. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.09.004 · Cited by 352
Metadata
- Authors
- McDonald, E. S., Clark, A. S., Tchou, J., Zhang, P., & Freedman, G. M.
- Venue
- Journal of Nuclear Medicine
- Publisher
- Society of Nuclear Medicine
- Published
- 2016-02
- Volume
- 57
- Issue
- Supplement 1
- Pages
- 9S-16S
- ISSN
- 0161-5505 (ISSN-L)
- 2159-662X
- OpenAlex
- W2269332562
- Cited by
- 613
- References
- 62
- FWCI
- 5.34
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.